Michael Morneau
Overview
Michael Morneau received an average of $587K in total compensation, including $240K in salary, at Viking Therapeutics from 2014 to 2018.
Source: SEC filings on April 5, 2019, April 6, 2018, April 7, 2017, and April 12, 2016.
Related executives
We found six more executives who work or worked at Viking Therapeutics.
Brian Lian
Viking Therapeutics
Chief Executive Officer
Marianne Mancini
Viking Therapeutics
Chief Operating Officer
Greg Zante
Viking Therapeutics
Chief Financial Officer
Hiroko Masamune
Viking Therapeutics
Former Chief Development Officer
Rochelle Hanley
Viking Therapeutics
Chief Medical Officer
Michael Dinerman
Viking Therapeutics